Page images
PDF
EPUB

results of research initiated in Phase I and scientific and technical merit and commercial potential of the Phase II application. Research must directly support the Family Smoking Prevention and Tobacco Control Act and the Center for Tobacco Products, Food and Drug Administration Research Priorities found at

http://www.fda.gov/downloads/TobaccoProducts/News Events/UCM293998.pdf

Applicant Eligibility:

Applicants should review the eligibility information in the individual funding opportunity announcements issued under this CFDA.

Beneficiary Eligibility:

This Tobacco Control Regulatory Research Program will support research aimed at providing guidance and evidence to develop regulation for tobacco product manufacturing, distribution and marketing. The general public will ultimately benefit.

Credentials/Documentation:

No Credentials or documentation are required. This program is excluded from coverage under 2 CFR 200, Subpart E - Cost Principles. Preapplication Coordination:

Preapplication coordination is generally not applicable, though applicants requesting direct costs of $500,000 or more for any one year must contact the appropriate NIH Institute or Center no later than 6 weeks before the anticipated submission date. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372. Application Procedures:

This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. Most applications must be prepared and submitted electronically. Most applicants use the SF 424 (Research & Related) for electronic submission. Information about the SF 424 form may be found on http://grants.nih.gov/grants/funding/424/index.htm, but application packages should be accessed through the appropriate funding opportunity announcement, found either on the NIH Guide to Grants and Contracts

(http://grants 1.nih.gov/grants/guide/index.html) or through the Grants.gov website (http://www.grants.gov/). Some institutions may submit the grant data directly (using what is called a system-to-system transfer). For further details, see grants.gov or eRA Commons. Application forms for SBIR and STTR grants may be obtained through the SBIR/STTR funding announcements posted on the NIH Guide to Grants and Contracts and the Grants.gov sites (see URLs listed above). All SBIR and STTR applications must be submitted electronically. The timeline for transition to electronic applications and the new forms may be found at: http://era.nih.gov/ElectronicReceipt/. For further assistance contact Grants Info, Telephone (301) 435-0714, Email: GrantsInfo@nih.gov. Consultation on a proposed project may be obtained from the Office of Disease Prevention in the Division of Program Coordination, Planning, and Strategic Initiatives at NIH. Applications are reviewed by principally nonfederal consultants recruited nationwide. The amounts of the award and period of support are determined on the basis of merit of the project and the nature of the grant mechanism. Electronic applications are submitted through the Grants.gov website.

Award Procedure:

All applications for research grants, cooperative agreements, training, and SBIR and STTR grants are evaluated for scientific and technical merit by an appropriate scientific peer review panel and by the National Advisory Council of the NIH Institute or Center that will manage the award. All competitive applications compete for available funds on the basis of scientific and technical merit, program relevance, and program balance. FDA Center for Tobacco Control will make final decisions on the relevance and program balance. Deadlines:

Contact the headquarters or regional office, as appropriate, for application deadlines.

Range of Approval/Disapproval Time:

> 180 Days. Review the individual Funding Opportunity Announcement under this CFDA for any application-specific deadlines. Appeals:

A principal investigator may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is availa on the NIH homepage

http://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html.

[graphic]

Renewals:

Renewal grants may only be submitted in response to a specific funding opportunity announcement under this CFDA.

Formula and Matching Requirements:

This program has no statutory formula.
This program has no matching requirements.
This program does not have MOE requirements.
Length and Time Phasing of Assistance:

Award length may vary depending on the recommendation of the scientific review group, the national advisory council, successful annual performance. and availability of funds, with project periods ranging from 1 to 5 years. Funding commitments are made annually. See the following for information how assistance is awarded/released: A formal notification in the form of a Notice of Award (NOA) will be provided to the applicant organization. Reports:

Annual progress and financial status reports for continuing projects and final reports on all projects upon conclusion are required. Cash are applicable and will be submitted on the SF425. Annual progress reports for continuing projects are required to assess progress. Interim reports may also be required or requested. Expenditure reports are applicable and will be submitted monthly a the SF425. No performance monitoring is required. Audits:

In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,00 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. Records:

Expenditures and other financial records, and also administrative records, mus be retained for 3 years from the day on which the grantee submits the last expenditure report for the grant period.

Scientific data must be maintain to comply with Circular A-110 Shelby

Amendment.

Account Identification:

75-2016-0-6-000- 204B FDA IDDA REIMBURSABLE CATEGORY B. Obligations:

(Project Grants) FY 15 $110,819,293; FY 16 est $97,560,000; and FY 17 $87,000,000 - Funds provided by the FDA CTP through an IDDA to NIH the support of Family Smoking Prevention and Tobacco Control Act. Range and Average of Financial Assistance:

No Data Available.

TAFS Codes:

[graphic]

75-0846.

PROGRAM ACCOMPLISHMENTS:
Not Applicable.

REGULATIONS, GUIDELINES, AND LITERATURE:
45 CFR 74; 42 CFR 52; Guidelines are included in Funding Opportunity
Announcements. Grants will be available under the authority of and

administered in accordance with the NIH Grants Policy Statement and Feder

regulations at 42 CFR Part 52 and 42 CFR Part 52a; Administrative requirements at 45 CFR Part 74.

Regional or Local Office:

None.

Headquarters Office:

Helen I. Meissner, ScM, PhD National Institutes of Health

December 201

[merged small][merged small][ocr errors][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][ocr errors][merged small]

commer

ERIA FOR SELECTING PROPOSALS:

ng decisions are based on scientific merit (42 CFR 52h) and program nce. Scientific merit review encompasses: the peer review criteria d in the specific funding announcement, as well as the significance, ch, and innovation of the proposed research; the competency of the pal investigator; the adequacy of the resources and environment; the ted budget and requested period of support; and, where applicable, the acy of the measures for protecting against adverse effects upon humans, Is, or the environment. Relevance to Tobacco Control Regulatory rch program priorities will also be taken into consideration.

[ocr errors]
[merged small][merged small][merged small][ocr errors][merged small]

ES OF ASSISTANCE:

rative Agreements; Project Grants

CAND USE RESTRICTIONS:

funds may only be used for planning health information and promotion ies and materials that are related to strengthening emergency care ry and the development of regionalized, coordinated and accountable is of emergency care. Grants funds may not be used for basic research cientific or medical experiments.). When appropriated and apportioned, gids available will be used for discretionary grant awards. tant Eligibility:

stic public or private non-profit entities including state and local iments, Indian tribal governments and organizations (American /Alaskan Native/Native American), faith-based organizations, unity-based organizations, hospitals, and institutions of higher education. ciary Eligibility:

stic public or private non-profit entities including state and local iments, Indian tribal governments and organizations (American /Alaskan Native/Native American), faith-based organizations, lunity-based organizations, hospitals, and institutions of higher education. Entials/Documentation:

Pants should review the individual Assistant Secretary for Preparedness esponse (ASPR) funding opportunity announcement (FOA) issued under DA program for any proof of certifications which must be submitted

o or simultaneous with submission of an application package. OMB ar A-122 applies to this program. OMB Circular No. A-87 applies to this m. 2 CFR 200, Subpart E-Cost Principles applies to this program. plication Coordination:

Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.

Application Procedures:

2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Applicants should review the individual Assistant Secretary for Preparedness and Response (ASPR) funding opportunity announcement (FOA) issued under this CFDA program for any proof of certifications which must be submitted prior to or simultaneous with submission of an application package. OMB Circular A-122 applies to this program. OMB Circular No. A-87 applies to this program. Award Procedure:

Applications that successfully proceed through initial screening (as outlined in the FOA) will be objectively reviewed based upon the review criteria specified in the FOA. Applications selected for funding will be processed and the applicant notified in writing through the issuance of a Notice of Grant Award from the Office of the Assistant Secretary for Preparedness and Response. Deadlines:

Aug 30, 2012 Applicable deadlines and due dates are specified in the funding opportunity announcement.

Range of Approval/Disapproval Time:

From 30 to 60 days. From 30 to 120 days.
Appeals:

Not Applicable. Renewals:

Not Applicable.

Formula and Matching Requirements:
This program has no statutory formula.
This program has no matching requirements.
This program does not have MOE requirements.
Length and Time Phasing of Assistance:

Project periods are from 6 months and up to 5 years. Budget periods are from 6 months and up to 12 months. See the following for information on how assistance is awarded/released: Awardee is issued a Notice of Grant Award, a legal document that informs the awardee that a grant award has been made. See the following for information on how assistance is awarded/released:. See the following for information on how assistance is awarded/released: Awardee may draw down funds in advance of the incursion of expenditure (up to three days) from the Payment Management System.

Reports:

Grantees are required to submit program reports, also known as Program Progress Reports. Recipients must report cash transaction data via the Payment Management System (PMS) using the cash transaction data elements captured on the Federal Financial Report (FFR), Standard Form (SF) 425. The FFR SF425 cash transaction report is due 30 days after the end of each calendar quarter. Grantees are required to submit Program Progress Reports at the completion of each milestone as well as a final Program Progress Report. ASPR requires financial reporting through the Federal Financial Report (FFR), Standard Form 425. Reports are due semi-annually within 30 days after the first 6 month period and within 90 days of the budget period end date. Performance monitoring of awardees is completed by ASPR program staff. Specific reporting conditions will be outlined in the terms and conditions of the Notice of Award and may vary. Recipients must report cash transaction data via the Payment Management System (PMS) using the cash transaction data elements captured on the Federal Financial Report (FFR), Standard Form (SF) 425. The FFR SF425 cash transaction report is due 30 days after the end of each calendar quarter. Specific reporting conditions will be outlined in the terms and conditions of the Notice of Award and may vary. Grantees are required to submit program reports, also known as Program Progress Reports. Specific reporting conditions will be outlined in the terms and conditions of the Notice of Award and may vary. ASPR requires financial reporting through the Federal Financial Report (FFR), Standard Form 425. Reports are due semi-annually within 30 days after the first 6 month period and within 90 days of the budget period end date. Performance monitoring of awardees is completed by ASPR

am Descriptions

program staff. Specific reporting conditions will be outlined in the terms and conditions of the Notice of Award and may vary. Performance monitoring is not applicable.

Audits:

In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503.

Records:

Records must be kept available for 3 years after submission of the final expenditure report.

Account Identification:

75-0140-0-1-551.

Obligations:

(Cooperative Agreements) FY 15 Not Available; FY 16 est $400,000; and FY 17 est $400,000

Range and Average of Financial Assistance:

No Data Available.

TAFS Codes:

75-1013-014.

PROGRAM ACCOMPLISHMENTS:

Not Applicable.

REGULATIONS, GUIDELINES, AND LITERATURE:

Not Applicable.

Regional or Local Office:

None.

Headquarters Office:

Kristen Finne Office of Policy and Planning, Division of Health Systems Policy, Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, O'Neill Federal Building, 200 C Street SW, 1st Floor, Cube C1A04, Washington, District of Columbia, 20024, Washington, District of Columbia 20024 Email: kristen.finne@hhs.gov Phone: 202-631-2013

Website Address:

http://www.phe.gov

RELATED PROGRAMS:

Not Applicable.

EXAMPLES OF FUNDED PROJECTS:

Not Applicable.

CRITERIA FOR SELECTING PROPOSALS:

Discretionary awards are subject to objective review. Reviewers will individually evaluate and score applications based upon the review criteria specified in the funding opportunity announcement. Scored applications will be ordinally ranked. The highest ranked applications will receive priority consideration for award within available funding.

93.079 COOPERATIVE AGREEMENTS TO PROMOTE ADOLESCENT HEALTH THROUGH SCHOOL-BASED HIV/STD PREVENTION AND SCHOOL-BASED SURVEILLANCE

NA

Centers for Disease Control and Prevention, Department of Health and Human Services

Public Health Service Act, Title III, Part B, Section 317(b)(k)(2), 42 U.S.C 247(b)(k)(2).

Funding will build the capacity of state, territorial, and local (STL) agencies

[merged small][graphic]

TYPES OF ASSISTANCE:

Cooperative Agreements

USES AND USE RESTRICTIONS:

Throughout the 5-year cooperative agreement, awardees will conduct the You Risk Behavior Survey (YRBS) and the School Health Profiles (Profiles) and will aim to improve the sexual health of high school students within their jurisdiction by delaying the onset of sexual activity; reducing the number of sexual partners; promoting the dual use of condoms and a highly effective contraceptive method among adolescents who are sexually active; increasing STD and HIV testing, counseling, and treatment; and addressing key social determinants of health to ensure we are reaching youth at most disproportion risk for HIV infection and other STD. Separate funding pools are available fr State and Territorial Education Agencies (SEA/TEA); Local Education Agencies (LEA); and National Non-Governmental Organizations. In addition state, territorial, and local health agencies may be eligible for School-Bad Surveillance funding if the education agency in their jurisdiction does not for it. Funding will be for agencies and organizations to implement four y strategies:

Strategy 1: School-Based Surveillance

Strategy 2: School-Based HIV/STD Prevention

Strategy 3: Capacity Building Assistance for School-Based HIV/STD Prevention

Strategy 4: School-Centered HIV/STD Prevention for Young Men Who Have Sex with Men.

Cooperative agreement funds may be used to support personnel, purchase equipment, supplies, services, and travel directly related to program activites and consistent with the scope of this program. Cooperative agreement funds are used to help schools prevent sexual risk behaviors that result in HIV and STD infection, especially among youth who are at highest risk. CDC believe that the specific scope and content of HIV education programs in schools should be locally determined and should be consistent with parental and community values. CDC supports local decision making by providing sound scientific information to grantees who work directly with schools, commun and parents. Funds may be expended for written materials, pictorials, audiovisuals, questionnaires, or survey instruments, and educational group sessions related to HIV education youth, school, and college populations if approved in accordance with the document Content of AIDS-Related White Materials, Pictorials, Audiovisuals, Questionnaires, Survey Instrument, and Educational Sessions in Centers for Disease Control and Prevention (CDC) Assistance Programs. Cooperative agreement funds are also used to buld state education and state health agency partnership and capacity to impleme and coordinate school health programs across agencies and within schok fr example, cooperative agreement recipients implement and integrate effective policies, environmental changes, and educational strategies to reduce nily behaviors; leverage resources to avoid duplication at the state and local leve and evaluate school health capacity-building efforts while implementing

effective strategies to reduce priority health risks. Funds may not be used to
conduct research projects, provide direct delivery of patient care or treatment
services, or purchase or disseminate condoms. Although public health may
have an assurance role in clinical testing and screening, funds are not least

to provide clinical testing or screening services. Funds may not be used for
purchasing computer equipment, office equipment, or furnishing, renting

leasing office space, or to support constructions or renovation unless
specifically approved.

[graphic]

All 50 state education agencies, plus the District of Columbia, and the temi education agencies in Puerto Rico, the U.S. Virgin Islands, American Sam Northern Mariana Islands, Federated States of Micronesia, Guam, Republic the Marshall Islands, and Republic of Palau are eligible to apply for Strategi

December 2

SEA and TEA are not eligible for Strategy 3. If a state or territorial dimion agency declines to apply for Strategy 1, the health agency in the same diction or the health agencys Bona Fide Agent may apply on their behalf. ot the education agency or the health agency in a state or territory must be alted for Strategy 1 and include at least four of the seven sexual behavior

ons on the 2015 YRBS questionnaire in order for the education agency in ite or territory to be awarded for Strategy 2. SHA/THA are not eligible ategy 2, 3 or 4. Thirty-one local education agencies are eligible to te for Strategies 1 and 2, and twelve of the 31 LEA are eligible to te for Strategy 4. LEA are not eligible for Strategy 3. If a local

Lion agency declines to apply for Strategy 1 funding, the health agency in ne jurisdiction or the health agencys Bona Fide Agent may apply on its bble Either the local education agency or the health agency in the same iction must be awarded for Strategy 1 and include at least four of the

sexual behavior questions on the 2015 YRBS questionnaire in order for ocation agency in that jurisdiction to be eligible for funding for Strategies .LHA are not eligible for Strategy 2, 3 or 4.

[ocr errors][merged small][ocr errors][ocr errors][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small]

ation Deadline Date: April 26, 2013, 11:59 p.m. U.S. EST, on rants.gov, Phase I Review: all eligible applications will be initially ed for completeness by the CDCs Procurement and Grants Office staff. In addition, eligible applications will be jointly reviewed for siveness by the CDC and PGO. Incomplete applications and applications non-responsive to the eligibility criteria will not advance to Phase II Applicants will be notified that the application did not meet eligibility "published submission requirements. Phase II Review: An objective panel will evaluate complete and responsive applications according to eria listed in the criteria section of the funding opportunity acement (FOA) for all strategies. This review will consist of a mmatic and budget assessment to ensure that the proposed project is ally and scientifically sound and the awarded entity is capable of

performing the project. Applicants will be provided a copy of the technical, scientific, and budget assessment of their application. Phase III Review: All applications deemed eligible and technically acceptable by the review panel will be awarded in order of score and rank within their funding tier. In addition, the following factors may affect the funding decision: availability of funds and geographic diversity. Strategy 2 will be awarded after awards have been determined for the LEA awarded in Strategy 1. Strategy 4 will be awarded after awards have been determined for Strategy 2. It is anticipated that a variety of NGO will be awarded in Strategy 3. CDC will provide justification for any decision to fund out-of-rank order; factors such as geographical distribution and organizational diversity will be taken into consideration when making final funding decisions. Successful awardees will receive an electronic copy of the Notice of Award (NoA) from PGO. The NoA shall be the only binding, authorizing document between the awardee and CDC. The NOA will be signed by an authorized grants management official (GMO) and emailed to the awardee program director. Any application awarded in response to the FOA will be subject to the DUNS, SAM Registration and Federal Funding Accountability And Transparency Act Of 2006 (FFATA) requirements. Unsuccessful applicants will receive notification of the results of the application review by email with delivery receipt or by mail.

Deadlines:

Not Applicable.

Range of Approval/Disapproval Time:

From 90 to 120 days.

Appeals:

Not Applicable.

Renewals:

From 60 to 90 days. Renewals will be based upon the conditions in the funding opportunity announcement and are subject to the availability of funds under Section 317 of the Public Health Service Act.

Formula and Matching Requirements:

This program has no statutory formula.
This program has no matching requirements.
This program does not have MOE requirements.
Length and Time Phasing of Assistance:

Project period can be up to 5 years. Budget periods are for 12 months.
Payment under this program is made available through HHS Payment
Management System (PMS) Method of awarding/releasing assistance. Method
of awarding/releasing assistance: lump sum.

Reports:

No program reports are required. No cash reports are required. The awardee must submit the Annual Performance Report (APR) via www.grants.gov 120 days before the end of the budget period.

Performance Measures (including outcomes) Awardees must report on performance measures for each budget period and update measures, if needed Evaluation Results Awardees must report evaluation results for the work completed to date (including any impact data)

Work Plan Awardees should update work plan each budget period.
Administrative Reporting

SF-424A Budget Information-Non-Construction Programs
Budget Narrative

Indirect Cost Rate Agreement. The Annual Federal Financial Report (FFR) SF 425 is required and must be submitted through www.grants.gov within 90 days after the end of each budget period. The FFR should only include those funds authorized and disbursed during the timeframe covered by the report. The final FFR must indicate the exact balance of unobligated funds and may not reflect any unliquidated obligations. There must be no discrepancies between the final FFR expenditure data and the Payment Management Systems (PMS) cash transaction data. Failure to submit the required information in a timely manner may adversely affect the future funding of this project. If the information cannot be provided by the due date, you are required to submit a letter explaining the reason and date by which the Grants Management Officer will receive the information. CDC programs require awardees to submit performance measures at least annually. CDC may require more frequent reporting of performance measures. Performance measure reporting should be

limited to the collection of data. CDC/DASH will require reporting at least semi-annually, due 120 days before the end of the budget period as part of the Annual Performance Report and 90 days after the end of each budget period. Audits:

In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. Records must be available for review or audit by appropriate officials of the Federal agency, pass-through entity, and General Accounting Office (GAO). The grantee is to also ensure that the sub-recipients receiving CDC funds also meet these requirements (if total Federal grant or grants funds received exceed $500,000). The grantee should include this requirement in all sub-recipient contracts.

Records:

Financial records, supporting documents, statistical records, and all other records pertinent to the program shall be retained for a minimum of 3 years, or until completion and resolution of any audit in process or pending resolution. In all cases records must be retained until resolution of any audit questions. Account Identification:

79-0950-0-1-550.

Obligations:

(Cooperative Agreements) FY 15 $18,031,115; FY 16 est $18,443,751; and FY 17 est $18,443,751 - Future year funding is subject to the availability of funds. Range and Average of Financial Assistance:

Awards will range from approximately $7,000 to $650,000 (subject to the availability of funds), with an average of approximately $375,000, depending on the specific components funded.

TAFS Codes:

75-15-16-0950.

PROGRAM ACCOMPLISHMENTS:

Fiscal Year 2015: DASH funded partners have worked to build the capacity of secondary schools to:

implement exemplary sexual health education programs;

increase student access to sexual health services including HIV and STD testing;

create safe and supportive environments for all students, particularly those at greatest risk for HIV infection and other STDs; and

assess existing school policies related to HIV/STD prevention and educate key decision makers on policy issues. Fiscal Year 2016: DASH funded partners have worked to build the capacity of secondary schools to: implement exemplary sexual health education programs;

increase student access to sexual health services including HIV and STD testing;

create safe and supportive environments for all students, particularly those at greatest risk for HIV infection and other STDs; and

assess existing school policies related to HIV/STD prevention and educate key decision makers on policy issues. Fiscal Year 2017: DASH funded partners have worked to build the capacity of secondary schools to:

implement exemplary sexual health education programs;

increase student access to sexual health services including HIV and STD testing;

create safe and supportive environments for all students, particularly those at greatest risk for HIV infection and other STDs; and

assess existing school policies related to HIV/STD prevention and educate key decision makers on policy issues.

REGULATIONS, GUIDELINES, AND LITERATURE:

Regulations governing this program are published under 45 CFR Part 74 and 45 CFR Part 92. Program guidelines are available from the Grants Management Contact.

Headquarters Office:

John Canfield, CDC NCHHSTP

[graphic]

1600 Clifton Road NE, MS E-75, Atlanta, Georgia 30333 Email: qzc6@cdc.gov Phone: 404-718-8333 Fax: 404-718-8045 Website Address:

http://www.cdc.gov/healthyyouth

RELATED PROGRAMS:

Not Applicable.

EXAMPLES OF FUNDED PROJECTS:

Fiscal Year 2015: Texas Department of State Health Services
New Hampshire Department of Education
Montana Office of Public Instruction

North Dakota Department of Public Instruction
Ohio Department of Health

South Dakota Department of Health
New York City Board of Education (NY)
West Virginia Department of Education
New York State Education Department
American Psychological Association (APA)
North Carolina Department of Public Instruction
District of Columbia Public Schools (DC)
Oakland Unified School District (CA)
DeKalb County Board of Health (GA)
Kansas State Department of Education
Gay Straight Alliance Network (GSAN)
Duval County Public Schools (FL)
Houston Independent School District (TX)
Iowa Department of Education

Massachusetts Department of Elementary & Secondary Education
Oklahoma State Department of Health
School Board of Orange County (FL)
Michigan Department of Education
New Jersey Department of Education
Oregon Health Authority

Pennsylvania Department of Education
School District of Philadelphia (PA)
Advocates for Youth (AFY)

Alaska Department of Health and Social Services
Arizona Department of Education

Arkansas Department of Education

Chicago Public Schools (IL)

California Department of Education
Cicatelli Associates Inc.

Cleveland Municipal School District (OH)

Colorado Board of Education

Connecticut State Department of Education

District of Columbia Office of the Superintendent of Education Delaware Department of Education

School District of the City of Detroit (MI)

Ft. Worth Independent School District (TX)
Georgia Department of Public Health
Healthy Teen Network (HTN)
Idaho State Department of Education
Indiana State Department of Health
Illinois State Board of Education

Rhode Island Department of Elementary & Secondary Education
Kentucky Department of Education

Los Angeles Unified School District (CA)
Louisiana Department of Education
Maine Department of Education
Maryland State Department of Education
San Diego Unified School District (CA)
School Board of Palm Beach County (FL)
School Board of Miami-Dade (FL)

Minnesota Department of Education

Missouri Department of Elementary & Secondary Education

[graphic]

December

« PreviousContinue »